Financial Year |
March 31 2020 |
Monetary Funds |
1,110,441.36 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
2,781,474.50 |
Accounts Receivable |
55,865,024.81 |
Advances to Suppliers |
7,330,140.17 |
Other Receivables |
2,220.09 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
1,913,372.41 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
544,268.83 |
Total Current Assets |
69,546,942.17 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
16,000,000.00 |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
497,904,648.84 |
Under-construction Projects |
2,638,506.78 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
-- |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
-- |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
516,543,155.62 |
Total Assets |
586,090,097.79 |
Short-Term Loans |
231,491,699.70 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
271,546,706.86 |
Accounts Received In Advance |
29,369,801.73 |
Employee Compensation Payable |
1,147,136.34 |
Taxes Payable |
1,676,599.24 |
Interest Payable |
56,863,844.61 |
Dividend Payable |
-- |
Other payables |
186,691,996.50 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
40,936,606.64 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
762,860,547.01 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
34,745,968.32 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
34,745,968.32 |
Total Liabilities |
797,606,515.33 |
Paid-In Capital(Or Share Stock) |
275,000,000.00 |
Capital Surplus |
519,405,265.08 |
Surplus Reserve |
15,404,353.58 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-1,021,326,036.20 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-211,516,417.54 |
Owner's Equity(Stockholder's Equity) |
-211,516,417.54 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
586,090,097.79 |